Escolar Documentos
Profissional Documentos
Cultura Documentos
2 Histological Types
Hodgkins
Non-Hodgkins
Incidence 15/100,000
Incidence 3/100,000
patients)
Mostly B-cell
(developed countries)
Age >50 years, except
high-grade common in
children
?EBV (20% patients)
B cell (90%) or T cell in
origin
Many subtypes such as
Burkitts
Presentation
Painless
lymphaden
opathy
Extranodal
symptom
s
Signs &
Symptom
s
Systemic
B
symptoms
Hepatosplenome
galy
B Symptoms
Fever
Night sweats
Weight loss
Differential
Autoimmune
eg. rheumatoid
arthritis,
sarcoidosis,
Kawasakis
Primary lymph
node
malignancy
(inc. leukemia)
Secondary
malignancy eg.
Thyroid,
laryngeal, lung,
breast, stomach
Chronic
infection eg.
TB, syphilis,,
HIV
Acute infection
eg. CMV, EBV,
cat-scratch,
toxoplasmosis
Neck
Lum
p
Drugs eg.
Phenytoin
Investigations
Bloods
FBC anaemia,
lymphopenia, neutropenia,
thrombocytopenia
ESR - raised
U&E renal impairment due
to ureteric obstruction
(NHL)
LFT hepatic involvement
Serum uric acid raised
LDH raised, prognostic
Serum immunoglobulins -
low in NHL
Imaging
CXR mediastinal
widening, lung
involvement eg. hilar
lymphadenopathy,
staging
CT staging,
involvement of thoracic,
abdominal or pelvic
lymph nodes
Histology
Cytology
Immunophenotyping
Hodgkins or Non-Hodgkins?
T-cell or B-cell?
Primary site?
DIAGNOSTIC
of lymph nodes
Stage 2 2 or more areas of
Hodgkins
Cervical nodes
Chest
Pruritis
Fatigue
Anorexia
Hodgkins
Nodular lymphocyte predominant
Classical (90%)
Nodular sclerosis (70%)
Lymphocyte-rich (5%)
Mixed cellularity
Lymphocyte-depleted
Hodgkins
Hodgkins
Management
Almost always treat to
cure
Chemotherapy (ABVD)
Leukemia
IHD
Breast & lung cancer
Long-term infertility
Radiotherapy
Close surveillance for
recurrence
Adverse prognostic:
Presence of B
symptoms
Low serum albumin
Low haemoglobin
Age (45) & Sex (M)
Stage 4
Leucocytosis
Lymphopenia
Non-Hodgkins
Peripeheral
lymphadenopathy
More
commonly
extranodal
(40%) eg. GI,
brain, testes,
thyroid, skin
Hepato-
splenomegaly
Bone marrow
involvement
Non-Hodgkins
High grade vs. Low grade
2 commonest types DLBCL & follicular
EBV, HIV, H. Pylori
Pesticides
Non-Hodgkins
Bleeding
, DIC
Cardiac
problem
s
Pain
Bowel
obstruction
,
perforation
Complicatio
ns
SVC
obstruction
Neurological
problems
Spinal cord
compression
Non-Hodgkins
Management
Varies with cytological
type
Watchful waiting in low-
grade asymptomatic
Chemotherapy
Radiotherapy
Immunotherapy
Surgery limited to local
Adverse prognostic:
Age >60 years
Stage III or IV
High serum LDH
ECOG status 2 or
higher
>1 extranodal site
involved
Non-Hodgkins MALT
Aetiology
Presentation
Gastric ALT
H. Pylori
Dyspepsia, epigastric
discomfor, gastric
bleeding
Skin ALT
?B. Burgdorferi
Multiple
pink/red/purple
macule/plaque/nodul
es on trunk and arms
Sjogrens, RA
Incidental on CXR,
hameoptysis, cough,
dypsnoea
Thyroid MALT
Hashimotos
Thyroid mass,
obstructive
symptoms
Ocular MALT
C. Psittaci
Painless conjunctival
injections,
photophobia, orange
mass in fornices
HIV
NHL 2nd most common cancer occurring in
developing it
Immunotherap
y
Monoclonal antibody
therapy Rituximab (antiCD20) treatment of
choice in follicular NHL,
and is being increasingly
used in other sub-types,
usually alongside
chemotherapy